Australian courts have ordered the makers of the brand to stop repackaging identical painkillers for different pains – where does marketing halt and deception launch?Lies advance in a wide range of ethical shapes and sizes. There are white ones,diplomatic ones, and there are mean, or self-serving ones. Apparently there are even kind,Christmassy ones.
The Australian federal court yesterday ordered the drug giant Reckitt Benckiser to stop selling identical products marketed as specific Nurofen varieties for back pain, period pain, or migraine pain and tension headaches. The company admitted the drugs sold in different coloured packets all contained the same active ingredient: 342mg of ibuprofen lysine. It also sold them at almost twice the price of Nurofen’s standard ibuprofen products.
Continue reading...
Source: theguardian.com